Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

4-aminopyridine (4-AP)

Preclinical

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Cocaine Use Disorder (CUD)Recruiting

Cocaine Use Disorder (CUD)Preclinical

Recruiting

Timeline

Expected Milestones

Q3 2027

PreclinicalRecruiting

Cocaine Use Disorder (CUD)

NCT07532460

Clinical

Trials by Indication[1]

Cocaine Use Disorder (CUD)1 trial

Randomised, Double-Blind, Placebo-Controlled, Crossover Study Investigating the Role of Potassium Channels in Working Memory Impairments of Chronic Cocaine Users

Recruiting·BBoris Quednow·Preclinical·NCT07532460·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for 4-aminopyridine (4-AP). U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for 4-aminopyridine (4-AP). EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Boris Quednow company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: BBoris Quednow

Related News